Georges GAUDRIAULT

En résumé

Entreprises

• MedinCell SA - Chief Scientific Officer

  2007 - 2016 Medincell is a private drug delivery company committed to the creation and development of long acting parenteral formulations. The corporation, founded in 2002, assists Human and Animal Health companies with BEPO™, its advanced polymeric drug delivery system. BEPO™ drastically improves action durations of small molecules, peptides and proteins after subcutaneous administration. The technology thus allows greater patient compliance and convenience thanks to advantageous pharmacokinetic profiles.
  My function was to head the scientific research operations. I was evaluating and setting scientific priorities as well as managing all intellectual property activities from patents filling to prosecution. I was supporting scientific discussion with client during key business development activities. As part of the executive team, I was participating in all the strategic decisions implicating scientific activities.

• ObeTherapy Biotechnology SAS - Scientific Director

  2002 - 2007 ObeTherapy is a french start-up biotech company dedicated to the discovery of new targets and the development of new drugs for obesity, hypercholesterolemia and type II diabetes based on lean and/or starvation phenotype. During these five years, I was managing the discovery activities (target validation, HTS screening, and medicinal chemistry)

• Institut Curie - Research Scientist

  PARIS 5 1999 - 2002 INSERM U528 «Signal transduction and Oncogenesis'',
  Inside the "Oncogenesis and signal transduction" group, I managed a small team focusing on cAMP-GEFII function in cAMP regulation of oncogenesis.

• Clayton Foundation for Peptide Biology - Research Scientist

  1996 - 1999 Clayton Foundation for Peptide Biology, Salk Institute,
  I initially worked on molecular biology of CRF receptors, one of the main regulators of stress. We discovered a new component of the signaling pathway of these receptors, the cAMP-GEFII. This protein bridge cAMP signaling pathway and some members of the small G-protein family

Formations

• Université Nice Sophia Antipolis

  Valbonne 1991 - 1996 Doctor of Philosophy

• Université Nice Sophia Antipolis

  Nice 1988 - 1989 Master of Science
  
  Université Nice Sophia Antipolis, France

Réseau

Pas de contact professionnel